DE60044119D1 - Reagentien und verfahren zur erkennung von erkrankungen der brust - Google Patents

Reagentien und verfahren zur erkennung von erkrankungen der brust

Info

Publication number
DE60044119D1
DE60044119D1 DE60044119T DE60044119T DE60044119D1 DE 60044119 D1 DE60044119 D1 DE 60044119D1 DE 60044119 T DE60044119 T DE 60044119T DE 60044119 T DE60044119 T DE 60044119T DE 60044119 D1 DE60044119 D1 DE 60044119D1
Authority
DE
Germany
Prior art keywords
breast
useful
diseases
reagent
tissue
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60044119T
Other languages
English (en)
Inventor
Patricia A Billing-Medel
Maurice Cohen
Tracey L Colpitts
Paula N Friedman
Julian Gordon
Edward N Granados
Steven C Hodges
Michael R Klass
Jon D Kratochvil
John C Russell
Stephen D Stroupe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Application granted granted Critical
Publication of DE60044119D1 publication Critical patent/DE60044119D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3015—Breast
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds
DE60044119T 1999-01-21 2000-01-21 Reagentien und verfahren zur erkennung von erkrankungen der brust Expired - Lifetime DE60044119D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23471699A 1999-01-21 1999-01-21
PCT/US2000/001452 WO2000043420A1 (en) 1999-01-21 2000-01-21 Reagents and methods useful for detecting diseases of the breast

Publications (1)

Publication Number Publication Date
DE60044119D1 true DE60044119D1 (de) 2010-05-20

Family

ID=22882506

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60044119T Expired - Lifetime DE60044119D1 (de) 1999-01-21 2000-01-21 Reagentien und verfahren zur erkennung von erkrankungen der brust

Country Status (8)

Country Link
US (1) US20060154291A1 (de)
EP (1) EP1144449B1 (de)
JP (1) JP2002540761A (de)
AT (1) ATE463508T1 (de)
CA (1) CA2358800C (de)
DE (1) DE60044119D1 (de)
ES (1) ES2343103T3 (de)
WO (1) WO2000043420A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6586572B2 (en) * 1998-12-28 2003-07-01 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
US6958361B2 (en) * 1998-12-28 2005-10-25 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
US6590076B1 (en) 1999-04-02 2003-07-08 Corixa Corporation Compositions for the treatment and diagnosis of breast cancer and methods for their use
US6528054B1 (en) 1998-12-28 2003-03-04 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
US6579973B1 (en) 1998-12-28 2003-06-17 Corixa Corporation Compositions for the treatment and diagnosis of breast cancer and methods for their use
US7598226B2 (en) 1998-12-28 2009-10-06 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
US6680197B2 (en) 1998-12-28 2004-01-20 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
US6573368B2 (en) 1998-12-28 2003-06-03 Corixa Corporation Compositions for the treatment and diagnosis of breast cancer and methods for their use
US6518237B1 (en) 1998-12-28 2003-02-11 Corixa Corporation Compositions for treatment and diagnosis of breast cancer and methods for their use
US6844325B2 (en) 1998-12-28 2005-01-18 Corixa Corporation Compositions for the treatment and diagnosis of breast cancer and methods for their use
US6969518B2 (en) 1998-12-28 2005-11-29 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
EP1248800A2 (de) 1999-11-30 2002-10-16 Corixa Corporation Kompositionen und methoden zur therapie und diagnose von brustkrebs
WO2004092212A2 (en) * 2003-04-15 2004-10-28 Sanofi Pasteur Limited Tumor antigens bfa5 for prevention and/or treatment of cancer
US8207314B2 (en) * 2003-05-16 2012-06-26 Sanofi Pasteur Limited Tumor antigens for prevention and/or treatment of cancer
US20100129289A1 (en) * 2006-05-18 2010-05-27 The Ohio State University Research Foundation Compositions and methods for the detection of vulnerable plaque

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2804445A1 (de) 1978-02-02 1979-08-09 Studiengesellschaft Kohle Mbh Verfahren zur herstellung von magnesiumhydriden
US5618695A (en) * 1995-06-07 1997-04-08 Mayo Foundation For Medical Education And Research DNA encoding HEM-1, a gene expressed by sclerosing hemangioma cells
US5736331A (en) * 1995-07-08 1998-04-07 Schering Corporation Method for identifying nucleic acids encoding c-fos promoter activating proteins
WO1998018945A1 (en) * 1996-10-31 1998-05-07 Abbott Laboratories Reagents and methods useful for detecting diseases of the breast
WO1998059049A1 (en) * 1997-06-20 1998-12-30 Abbott Laboratories Reagents and methods useful for detecting diseases of the breast
CA2292843A1 (en) * 1997-07-07 1999-01-21 Abbott Laboratories Reagents and methods useful for detecting diseases of the breast
EP1032689A1 (de) * 1997-11-17 2000-09-06 Abbott Laboratories Reagenzien und methoden zum nachweis von krankheiten der brust

Also Published As

Publication number Publication date
CA2358800C (en) 2015-03-17
CA2358800A1 (en) 2000-07-27
ATE463508T1 (de) 2010-04-15
US20060154291A1 (en) 2006-07-13
EP1144449A1 (de) 2001-10-17
EP1144449B1 (de) 2010-04-07
JP2002540761A (ja) 2002-12-03
WO2000043420A1 (en) 2000-07-27
ES2343103T3 (es) 2010-07-23

Similar Documents

Publication Publication Date Title
ATE364089T1 (de) Reagenzien und methoden zum nachweis von erkrankungen der brust
WO2000056352A3 (en) Reagents and methods useful for detecting diseases of the prostate
DE60044119D1 (de) Reagentien und verfahren zur erkennung von erkrankungen der brust
HRP20131047T1 (hr) Identifikacija antigena povezanih s tumorom za dijagnozu i lijeäśenje
DE60126592D1 (de) Verfahren, zusammensetzungen und kits zur identifizierung und überwachung von brustkrebs
WO2004053079A3 (en) Compositions, splice variants and methods relating to ovarian specific genes and proteins
HUP0200186A2 (en) Use of casb616 polypeptides and polynucleotides for cancer treatment
ATE403001T1 (de) Antigenbindungsfragmente die spezifisch krebszellen nachweisen, nukleotide die für diese fragmente kodieren, und deren verwendung zur vorbeugung und zum nachweis von krebs
DE69833572D1 (de) Verfahren zur bestimmung des metastasierungspotentials unter verwendung des asp1 gens
CA2395849A1 (en) NUCLEIC ACIDS, PROTEINS AND ANTIBODIES
WO2004092338A3 (en) Compositions, splice variants and methods relating to cancer specific genes and proteins
DE60129151D1 (de) Verfahren zur erkennung von eierstockkrebs mittels menschlichem kallikrein (hk6)
ATE229073T1 (de) Protein e25a, methoden zu dessen herstellung und anwendung
WO2007149948A3 (en) Compositions and methods for diagnosis and treatment of tumors
DE60137264D1 (de) Monoklonale antikörper und zelloberflächenantigene zum nachweis und zur behandlung von kleinzelligem lungenkrebs (sclc)
ATE292801T1 (de) Verfahren zum screening von inhibitoren von asp2
JP2010529843A5 (de)
ATE449171T1 (de) Reagentia und verfahren zum nachweis von brustkrankheiten
WO2002064741A3 (en) Compositions and methods relating to breast specific genes and proteins
EA200501197A1 (ru) Композиции и способы для лечения злокачественной опухоли с применением igsf9 и liv - 1
WO2000041516A3 (en) Reagents and methods useful for detecting diseases of the breast
WO1999031274A3 (en) Reagents and methods useful for detecting diseases of the pancreas
WO2004053075A3 (en) Compositions, splice variants and methods relating to breast specific genes and proteins
ATE405649T1 (de) Hemmstoff zur diagnose und behandlung von haemophilia a patienten
WO1999014357A3 (en) Reagents and methods useful for detecting diseases of the prostate, breast and ovary

Legal Events

Date Code Title Description
8364 No opposition during term of opposition